OpenVSafe by OpenVAERS
Search V-safe

LX2-18020-72528

4 vaccinations 4 coded responses 23 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
105 / NY
Registered
2021-10-01
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-08
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-29
    Dose 2 — Pfizer-BioNTech
  3. 2021-10-01
    Registered in v-safe
  4. 2021-10-01
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  5. 2021-10-02
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  6. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  8. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2021-10-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2021-10-09
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  12. 2021-10-16
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  13. 2021-10-23
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  14. 2021-10-30
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  15. 2021-11-06
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  16. 2021-11-13
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-01-01
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-04-02
    Survey response — 6 months, dose 3
    MedDRA: Graves' disease, Thyrotoxic crisis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Graves' disease and thyroid storm
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-04-02
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  20. 2022-04-06
  21. 2022-09-28
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  22. 2022-10-04
    Survey response — 12 months, dose 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: COVID and rebound COVID
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-10-04
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  24. 2022-10-05
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  25. 2022-10-05
  26. 2022-10-05
  27. 2022-10-12
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  28. 2022-10-19
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  29. 2022-10-27
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  30. 2022-11-02
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  31. 2022-11-11
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  32. 2022-12-28
    Survey response — 3 months, dose 4
    MedDRA: Nasopharyngitis — Feeling: Good
    Free text: Head cold
    MedDRA releases: 2024-11 · check-in free text available
  33. 2023-03-29
    Survey response — 6 months, dose 4
    MedDRA: Thyroidectomy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    MedDRA releases: 2024-11
  34. 2023-03-29
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  35. 2023-03-30
  36. 2023-03-30
  37. 2023-03-30
  38. 2023-04-04
  39. 2023-04-04
  40. 2023-04-04

Vaccinations

DoseDateManufacturerCo-administered
12021-03-08Pfizer-BioNTech No
22021-03-29Pfizer-BioNTech No
32021-10-02Pfizer-BioNTech Flu
42022-09-28Pfizer-BioNTech Flu

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 11 — 6 months, dose 3

2022-04-02

Symptoms: Graves' disease and thyroid storm

Release 12 — 12 months, dose 3

2022-10-04

Symptoms: COVID and rebound COVID

Release 12 — 3 months, dose 4

2022-12-28

Symptoms: Head cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDGraves' disease · · ✓
SDNasopharyngitis · · ✓
SDThyroidectomy · · ✓
SDThyrotoxic crisis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…